| (210) | Number of the EPO application | 20162018 |
| (220) | Filing date of the EPO application | 2020.03.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2021, 2021.11.17 |
| (110) | EPO patent number | 3811927 |
| (11) | Number of the document | MD 3811927 T2 |
| (21) | Number of the application | e 2022 0046 |
| (71) | Name(s) of applicant(s), code of the country | Sun Pharmaceutical Industries Ltd, IN; |
| (72) | Name(s) of inventor(s), code of the country | JOSHI Jaydip, IN;
THUMMAR Rakesh, IN;
AGRAWAL Sudeep, IN;
BHOWMICK Subhas Balaram, IN;
YADAV Arunkumar, IN;
THENNATI Rajamannar, IN; |
| (73) | Name(s) of owner(s), code of the country | Sun Pharmaceutical Industries Ltd, IN; |
| (54) | Title of the invention | A stable parenteral dosage form of cetrorelix acetate |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 9/08 (2006.01.01); A61K 38/09 (2006.01.01); A61K 47/12 (2006.01.01); A61P 15/00 (2006.01.01) |
| (19) | Country | IN |
| (41) | Date of publication of the application | 2022.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.03.31 |
| (30) | Priority | 201921043355, 2019.10.24, IN |
| (74) | Patent attorney | (Procedură) FOCŞA Valentin, bd. Renaşterii Naţionale, No. 6, of. 08, MD-2024, mun. Chişinău, Republica Moldova |